JP2024513231A5 - - Google Patents
Info
- Publication number
- JP2024513231A5 JP2024513231A5 JP2023561275A JP2023561275A JP2024513231A5 JP 2024513231 A5 JP2024513231 A5 JP 2024513231A5 JP 2023561275 A JP2023561275 A JP 2023561275A JP 2023561275 A JP2023561275 A JP 2023561275A JP 2024513231 A5 JP2024513231 A5 JP 2024513231A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid substitution
- sequence number
- selectively
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163171227P | 2021-04-06 | 2021-04-06 | |
| US63/171,227 | 2021-04-06 | ||
| PCT/US2022/023673 WO2022216823A1 (en) | 2021-04-06 | 2022-04-06 | Ert2 mutants and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024513231A JP2024513231A (ja) | 2024-03-22 |
| JP2024513231A5 true JP2024513231A5 (https=) | 2025-03-21 |
Family
ID=83546546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023561275A Pending JP2024513231A (ja) | 2021-04-06 | 2022-04-06 | Ｅｒｔ２変異体及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240150433A1 (https=) |
| EP (1) | EP4320228A4 (https=) |
| JP (1) | JP2024513231A (https=) |
| KR (1) | KR20240004433A (https=) |
| CN (1) | CN117321192A (https=) |
| AU (1) | AU2022255180A1 (https=) |
| CA (1) | CA3213591A1 (https=) |
| IL (1) | IL307269A (https=) |
| WO (1) | WO2022216823A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121002054A (zh) * | 2023-02-02 | 2025-11-21 | 森迪生物科学公司 | 改进的ert2突变体、诱导型细胞死亡系统及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1397382B1 (en) * | 2001-05-31 | 2008-08-06 | Novartis AG | Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| ES2439874T3 (es) * | 2002-05-29 | 2014-01-27 | Regeneron Pharmaceuticals, Inc. | Sistema de expresión en eucariotas inducible |
| EP1680447A2 (en) * | 2003-10-24 | 2006-07-19 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Orthogonal gene switches |
| US20160186208A1 (en) * | 2013-04-16 | 2016-06-30 | Whitehead Institute For Biomedical Research | Methods of Mutating, Modifying or Modulating Nucleic Acid in a Cell or Nonhuman Mammal |
| EP3585394A4 (en) * | 2017-02-23 | 2021-06-30 | Olema Pharmaceuticals, Inc. | COMPOSITIONS AND PROCEDURES FOR REGULATING IMMUNE SYSTEM ACTIVITY |
| KR102109820B1 (ko) * | 2018-04-16 | 2020-05-12 | 한양대학교 산학협력단 | 비스페놀 a와의 결합력이 향상된 돌연변이 에스트로겐 수용체 단백질 및 이를 이용한 박테리아 균주 |
-
2022
- 2022-04-06 JP JP2023561275A patent/JP2024513231A/ja active Pending
- 2022-04-06 CN CN202280035999.6A patent/CN117321192A/zh active Pending
- 2022-04-06 KR KR1020237037724A patent/KR20240004433A/ko active Pending
- 2022-04-06 IL IL307269A patent/IL307269A/en unknown
- 2022-04-06 WO PCT/US2022/023673 patent/WO2022216823A1/en not_active Ceased
- 2022-04-06 CA CA3213591A patent/CA3213591A1/en active Pending
- 2022-04-06 AU AU2022255180A patent/AU2022255180A1/en active Pending
- 2022-04-06 EP EP22785372.8A patent/EP4320228A4/en active Pending
-
2023
- 2023-10-05 US US18/481,805 patent/US20240150433A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hou et al. | Identification and purification of human Stat proteins activated in response to interleukin-2 | |
| Miyajima et al. | Use of the silkworm, Bombyx mori, and an insect baculovirus vector for high-level expression and secretion of biologically active mouse interleukin-3 | |
| Xia et al. | Cross-talk between transcription factors NF-κB and C/EBP in the transcriptional regulation of genes | |
| McStay et al. | xUBF contains a novel dimerization domain essential for RNA polymerase I transcription. | |
| Leutz et al. | Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationship to interleukin 6 and granulocyte colony stimulating factor. | |
| Widelitz et al. | Effects of cycloheximide on thermotolerance expression, heat shock protein synthesis, and heat shock protein mRNA accumulation in rat fibroblasts | |
| Santoro et al. | A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs | |
| EP0177568B1 (en) | Recombinant dna molecules | |
| KR101476010B1 (ko) | 고생산성 세포의 수립을 위한 발현 벡터 및 고생산성 세포 | |
| JP2024521408A5 (https=) | ||
| JPH05502463A (ja) | ハイブリツド成長因子 | |
| RU2002103870A (ru) | Человеческое моноклональное антитело против AILIM, костимулирующей молекулы передачи сигнала, и его фармацевтическое применение | |
| JP2024513231A5 (https=) | ||
| JPH111498A (ja) | Ｍｙｃ結合性亜鉛フィンガータンパク質、その製造方法及びその使用 | |
| JP2025510781A5 (https=) | ||
| JP2024528534A5 (https=) | ||
| JP2024513003A5 (https=) | ||
| JP3158376B2 (ja) | ヒトインターフェロンーβ２Ａ遺伝子 | |
| JPWO2022065444A5 (https=) | ||
| CA2097385A1 (en) | Promoter for expression and use thereof | |
| CN120424890A (zh) | 具有双重肿瘤靶向性的重组溶瘤腺病毒、其制备方法及其应用 | |
| CN115093476B (zh) | 花鲈II型干扰素IFN-γrel及其受体的抗病毒组合物和应用 | |
| CN114539429B (zh) | 融合蛋白组合物及其应用 | |
| Souliotis et al. | Identification and molecular analysis of the cuticle protein genes of Dacus oleae | |
| CA1341625C (en) | Recombinant mammalian gm-csf, dna encoding mammalian gm-scf and methods of use thereof |